F. A. Waldvogel
Impact in
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus
- Microbiology top 0.5%
Papers in
-
- Antimicrobial Resistance in Staphylococcus 27
- Microbiology 10
- Co-authors
- Pierre VaudauxP D LewMorton N. SwartzGerald MedoffDaniel P. LewW. ZimmerliUrs E. NydeggerH Vasey
- Journals
- The Journal of Infectious Diseases (17 papers)Journal of Clinical Investigation (6 papers)Antimicrobial Agents and Chemotherapy (6 papers)New England Journal of Medicine (6 papers)Infection and Immunity (5 papers)
- Partner nations
- SwitzerlandUnited StatesSweden
In The Last Decade
F. A. Waldvogel
110 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Infectious Diseases 1.8k
- Microbiology 493
- Surgery 3.1k
- Clinical Biochemistry 416
- Emergency Medical Services 376
Countries citing papers authored by F. A. Waldvogel
This map shows the geographic impact of F. A. Waldvogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. A. Waldvogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. A. Waldvogel more than expected).
Fields of papers citing papers by F. A. Waldvogel
This network shows the impact of papers produced by F. A. Waldvogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. A. Waldvogel. The network helps show where F. A. Waldvogel may publish in the future.
Co-authors
The 25 scholars most cited alongside F. A. Waldvogel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 0 | |
| 2 | 1997 | 440 | |
| 3 | 1995 | 4 | |
| 4 | 1993 | 86 | |
| 5 | 1993 | 117 | |
| 6 | 1992 | 10 | |
| 7 | 1992 | 4 | |
| 8 | 1990 | 45 | |
| 9 | 1989 | 8 | |
| 10 | 1989 | 30 | |
| 11 | 1989 | 14 | |
| 12 | 1989 | 193 | |
| 13 | High levels of complement breakdown products in tuberculous pleural effusions. | 1983 | 8 |
| 14 | 1979 | 12 | |
| 15 | Chimiothérapie prophylactique contre les germes anaérobies. | 1978 | 0 |
| 16 | [Usefulness of echocardiography in the diagnosis of bacterial endocarditis]. | 1977 | 0 |
| 17 | Endocardites bactériennes: aspects cliniques, bactériologiques et facteurs de pronostic | 1977 | 2 |
| 18 | Pouvoir pathogène de staphylocoques dorés résistants à la méthicilline | 1976 | 1 |
| 19 | [Perinatal transmission of Plasmodium falciparum malaria]. | 1975 | 1 |
| 20 | 1974 | 4 |
About F. A. Waldvogel
F. A. Waldvogel is a scholar working on Infectious Diseases, Microbiology, Molecular Medicine, Clinical Biochemistry and Immunology and Allergy, having authored 115 papers that have together received 7.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (27 papers), Orthopedic Infections and Treatments (18 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Bacterial biofilms and quorum sensing (9 papers), S100 Proteins and Annexins (8 papers), Infective Endocarditis Diagnosis and Management (8 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Infectious Diseases (1.8k citations), Microbiology (493 citations), Surgery (3.1k citations), Clinical Biochemistry (416 citations) and Emergency Medical Services (376 citations). F. A. Waldvogel has collaborated with scholars based in Switzerland, United States and Sweden. Frequent co-authors include Pierre Vaudaux, P D Lew, Morton N. Swartz, Gerald Medoff, Daniel P. Lew, W. Zimmerli, Urs E. Nydegger, H Vasey, Tullio Pozzan and Didier Pittet. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Clinical Investigation, Antimicrobial Agents and Chemotherapy, New England Journal of Medicine and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.